glp-1 binge eating drugs are effective for weight loss, but they come with risks. Besides common side effects like gastrointestinal problems, they may mask or worsen disorder symptoms or trigger symptoms among patients Experts express alarm that GLP-1
Description
Henry Meds reviewed: program model, medication options, eligibility, pricing, and editorial context
New nutritional deficiency at 12 months

Clinical trial data shows average weight loss on Ozempic, Wegovy, Mounjaro, and Zepbound

The 2025 Nobel Prize in Physiology or Medicine is awarded to Joel Habener, Svetlana Mojsov, and Jens Juul Holst for their discovery and development of GLP-1based therapeutics, which have revolutionized the treatment of diabetes and obesity worldwide. | 29 comments on LinkedIn

#Pharmacology #ClinicalPharmacology #DrugDiscovery #PharmaResearch #ObesityTreatment #HealthcareInnovation #DrugSafety
